Product Information
SPIRIVA HANDIHALER 18 MCG CAP is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $11.6895 per EA under NDC 00597007575. Its NADAC has been published 267 times since Feb 19, 2014.
Strength
18 ug/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597007575
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL; RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
TIOTROPIUM BROMIDE MONOHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA021395On Market Since
10/11/2005
Pharmacological Classes
Price Statistics
The NADAC for SPIRIVA HANDIHALER 18 MCG CAP has been published 267 times since Feb 19, 2014, and over the history we have for it it has declined 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.6895 per EA |
|---|---|
| All-time high | $19.3463 (Jan 1, 2025) |
| All-time low | $11.5764 (Jun 18, 2025) |
| 52-week high | $11.6895 |
| 52-week low | $11.5764 |
| Median price | $14.4697 |
| Average price | $14.1455 |
| Largest weekly change | +48.0% (Apr 17, 2024) |
| Weeks tracked | 267 |
| Tracking since | Feb 19, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SPIRIVA HANDIHALER 18 MCG CAP?
The current National Average Drug Acquisition Cost (NADAC) for SPIRIVA HANDIHALER 18 MCG CAP, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $11.6895 per EA (NDC 00597007575), effective Jun 24, 2026.
How has the price of SPIRIVA HANDIHALER 18 MCG CAP changed over time?
Over the history we have for it, the NADAC for SPIRIVA HANDIHALER 18 MCG CAP has declined 23.4%. It has been tracked across 267 weekly CMS publications since Feb 19, 2014.
What are the highest and lowest recorded NADAC prices for SPIRIVA HANDIHALER 18 MCG CAP?
Since Feb 19, 2014, the NADAC for SPIRIVA HANDIHALER 18 MCG CAP has ranged from a low of $11.5764 (Jun 18, 2025) to a high of $19.3463 (Jan 1, 2025), with a median of $14.4697 per EA.
Are there cheaper alternatives to SPIRIVA HANDIHALER 18 MCG CAP?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, SPIRIVA HANDIHALER 18 MCG CAP, is $10.6216 per EA — about 9% below SPIRIVA HANDIHALER 18 MCG CAP.
Who manufactures SPIRIVA HANDIHALER 18 MCG CAP?
SPIRIVA HANDIHALER 18 MCG CAP (NDC 00597007575) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification